Molecular Biology Reports Генетика

TRIM proteins in tuberculosis: from host defense to pathogen evasion and therapeutic innovation

Ghazanfari Jajin, Morteza, Jamnani, Fatemeh Rahimi, Fateh, Abolfazl
Springer Nature · 2026-11-15 · DOI 10.1007/s11033-026-13140-8

Аннотация

Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a major global health challenge, owing in part to the ability of the pathogen to evade host immunity and the growing burden of drug-resistant disease. This review examines the role of tripartite motif-containing (TRIM) proteins, a family of E3 ubiquitin ligases that regulate diverse aspects of host immunity during MTB infection. Several TRIM proteins, including TRIM16, TRIM22, TRIM27, and TRIM32, have been implicated in host-protective responses by regulating autophagy, lysosomal function, and inflammatory signaling, thereby contributing to intracellular bacterial control. In contrast, at least three TRIMs, TRIM21, TRIM25, and TRIM14, have been associated with impaired bacterial control: MTB can exploit TRIM21-dependent ferritinophagy to increase intracellular iron availability and create conditions favorable for bacterial persistence, and TRIM21 also limits host resistance through a ligase-independent mechanism in macrophages and mice; TRIM25 overexpression increases intracellular bacterial survival; and loss of TRIM14, which restrains type I interferon signaling, improves bacterial control in macrophages. Differences in TRIM expression among individuals with latent TB infection, active disease, and drug-resistant TB have also raised the possibility that selected TRIMs could serve as biomarkers of disease status. Mechanistic studies further point to TRIM-associated pathways as potential targets for host-directed therapy, either by limiting pathways exploited by MTB, such as TRIM21-mediated iron acquisition, or by strengthening protective responses such as the TRIM27–TFEB pathway. However, the functions of individual TRIM proteins are context dependent, and functional overlap among family members, together with the limited amount of in vivo evidence, remains an important challenge. Defining the specific contributions of TRIM proteins to MTB infection will therefore require further mechanistic, animal, and clinical studies before their diagnostic or therapeutic potential can be established.

Читать у издателя →